Stanford University School of Medicine says it’s about time that prescription drug labels reveal what isn’t known.
The Stanford researchers are asking the FDA to require drug makers to say how new medications compare with already existing similar treatments.

Randall Stafford, MD, PhD, associate professor of medicine at the Stanford Prevention Research Center, notes that manufacturers of drugs and medical devices benefit from an “information gap that develops as more and more products are tested against placebo, but not each other.” Stafford is the lead author of an essay published online in the New England Journal of Medicine on August 12. The …read more